6-Phenoxyl-4-aminoquinoline: synthesis and preliminary antitubercular-structure activity relationship analyses
Open Access
- 4 April 2025
- journal article
- research article
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 34 (5) , 1065-1073
Abstract
Diphenyl ether and quinoline based compounds have been reported to show antibacterial activity. Against Mycobacterium tuberculosis, drug targets inhibited by diphenyl ether compounds are reportedly different from those perturbed by quinoline based antitubercular hits/drugs. Herein, we conceptualized and synthesized novel molecules incorporating quinoline and diphenyl ether moieties. The antitubercular property of the synthesized compounds were measured in vitro using Tween 80 and Tyloxapol supplemented growth media. Compounds in this study generally showed sub micromolar antitubercular activity in tween 80/albumin supplemented growth medium, and moderate to poor activity in tyloxapol/casitone supplemented growth medium. Compound 4e, havin a trimethylenediamine moiety and low melting point of 68 °C, emerged as the hit compound, possessing MIC90 value of 0.2 µM. 4e is non-cytotoxic when tested against normal human cell line, exhibiting CC50 value > 20 µM.Keywords
This publication has 25 references indexed in Scilit:
- Tractable Quinolone Hydrazides Exhibiting Sub‐Micromolar and Broad Spectrum Antitrypanosomal ActivitiesChemMedChem, 2024
- Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysisJournal of Infection, 2023
- Building Machine Learning Small Molecule Melting Points and Solubility Models Using CCDC Melting Points DatasetJournal of Chemical Information and Modeling, 2023
- Novel diaryl ether derivatives as InhA inhibitors: Design, synthesis and antimycobacterial activityBioorganic Chemistry, 2022
- Easily accessed nitroquinolones exhibiting potent and selective anti-tubercular activityEuropean Journal of Medicinal Chemistry, 2021
- Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosisJournal of Medicinal Chemistry, 2020
- Quinoline Derivatives Kill Mycobacterium tuberculosis by Activating Glutamate KinaseCell Chemical Biology, 2019
- 4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluationEuropean Journal of Medicinal Chemistry, 2015
- Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and ManagementJournal of Clinical and Experimental Hepatology, 2013
- Lead- and drug-like compounds: the rule-of-five revolutionDrug Discovery Today: Technologies, 2004